Key result
Markedly elevated D-dimer differentiates acute aortic syndrome and PE from other chest pain causes.
Why the study?
D-dimer is elevated in acute aortic syndrome (AAS) and pulmonary embolism (PE), but local comparative data in Hong Kong are limited. This study evaluated the diagnostic value of D-dimer for AAS to inform acute chest pain management.
Does D-dimer testing differentiate acute aortic syndrome and pulmonary embolism from ischaemic heart disease and non-specific chest pain in adult emergency department patients presenting with acute chest pain?
Observational (n=1,019)
No
Does D-dimer testing differentiate acute aortic syndrome and pulmonary embolism from ischaemic heart disease and non-specific chest pain in adult emergency department patients presenting with acute chest pain?
In a Hong Kong emergency department cohort presenting with acute chest pain, D-dimer levels were markedly higher in acute aortic syndrome and pulmonary embolism than in ischaemic heart disease or non-specific chest pain, demonstrating high diagnostic accuracy (AUROC 0.84 for AAS and 0.93 for PE) while revealing underutilization of early ED CT imaging.
Answers are grounded in this paper and cite their sources.
D-dimer may aid differentiation of AAS/PE in acute chest pain; leaves open prospective validation before clinical adoption.
Background D-dimer is elevated in acute aortic syndrome (AAS) and pulmonary embolism (PE), but local comparative data is limited. This study explores D-dimer's diagnostic value for AAS to inform acute chest pain management. Methods This retrospective single-centre study in Hong Kong evaluated adult emergency department (ED) patients presenting with chest pain between 2020 and 2025. Patients with D-dimer testing were grouped by diagnosis: AAS, PE, ischaemic heart disease (IHD), or non-specific chest pain (CP). Outcomes included D-dimer levels, diagnostic performance of D-dimer for AAS and PE, computed tomography (CT) utilization, 7- and 30-day mortality, hospital length of stay, and 28-day readmission rates. Results Among 1,019 included patients, median D-dimer levels were 329, 531, 3738, and 4693 ng/mL for CP, IHD, PE, and AAS, respectively. The AUROC for distinguishing AAS from non-AAS was 0.84 (95% CI: 0.79–0.89). D-dimer ≥ 2000 ng/mL was associated with significantly higher mortality. ED-based CT scans were performed in only 3 (27.3%) of AAS and 15 (6.3%) of PE patients. Conclusions This study reports the first local data characterising D-dimer levels across acute chest pain aetiologies, with the highest values observed in AAS and PE. The notably low CT rates in both the AAS and PE groups highlight an unanswered clinical need, and prospective multicentre studies integrating biomarkers with validated clinical decision tools are warranted to optimise risk stratification and CT utilisation for high-risk ED patients with chest pain.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted an observational in Acute chest pain (n=1,019). D-dimer testing across chest pain diagnoses (Acute Aortic Syndrome, Pulmonary Embolism, Ischaemic Heart Disease) vs. Non-specific chest pain was evaluated on Median D-dimer level (ng/mL) across chest pain-related diagnoses (Acute Aortic Syndrome vs Non-specific Chest Pain) (AUROC 0.84 for distinguishing AAS from non-AAS, 95% CI 0.79-0.89, p=<0.01). D-dimer levels were higher in acute aortic syndrome and pulmonary embolism than in ischaemic heart disease or non-specific chest pain.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: